119171-39-0

Basic information

• Product Name: 2-[(2-methyl-2-propenyl)oxy]benzoic acid
• Synonyms: 2-[(2-methyl-2-propenyl)oxy]benzoic acid;2-[(2-METHYLPROP-2-EN-1-YL)OXY]BENZOIC ACID;AKOS BBB/624;UKRORGSYN-BB BBV-079390;2-[(2-methylprop-2-en-1-yl)oxy]benzoic acid(SALTDATA: FREE)
• CAS NO: 119171-39-0
• Molecular Formula: C₁₁H₁₂O₃
• Molecular Weight: 192.21
• Mol File: 119171-39-0.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 329.213°C at 760 mmHg
• Flash Point: 127.961°C
• Appearance: /
• Density: 1.128g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.538
• CAS DataBase Reference: 2-[(2-methyl-2-propenyl)oxy]benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[(2-methyl-2-propenyl)oxy]benzoic acid(119171-39-0)
• EPA Substance Registry System: 2-[(2-methyl-2-propenyl)oxy]benzoic acid(119171-39-0)

Safety Data

• Hazardous Substances Data: 119171-39-0(Hazardous Substances Data)

Usage

Occurrence

Essential oils of plants such as basil, cloves, and nutmeg

Odor

Sweet, spicy

Usage

Flavoring agent in food and beverages

Properties

Antimicrobial, antioxidant, anti-inflammatory

Potential uses

Pharmaceutical and cosmetic products

Health concerns

Potential carcinogen, regulatory restrictions in some countries

InChI:InChI=1/C11H12O3/c1-8(2)7-14-10-6-4-3-5-9(10)11(12)13/h3-6H,1,7H2,2H3,(H,12,13)

Upstream product

• 110124-06-6 2-(2-methyl-2-propenyloxy)benzoic acid,methyl ester 
• 119-36-8 methyl salicylate 
• 118-61-6 2-hydroxy-benzoic acid ethyl ester 

Downstream Products

• 42327-95-7 2,3-Dihydro-2,2-dimethyl-7-benzofurancarbonsaeure 
• 121767-60-0 2-methallyloxybenzoyl chloride 
• 478072-11-6 2-(2-methallyloxy)benzhydrazide 
• 478072-24-1 N'-(2-nitrobenzenesulfonyl)-2-(2-methallyloxy)benzhydrazide 
• 193806-57-4 2-(2-Methyl-allyloxy)-thiobenzoic acid S-[2-(2-tert-butoxycarbonylamino-phenyl)-ethyl] ester 
• 1061592-10-6 sodium 2-(2-methyl-allyloxy)-benzoate 

Relevant articles and documents

ALLYLQXY AND ALKYLOXY BENZOIC ACID DELIVERY AGENTS

The present invention relates to pharmaceutical compounds for delivering active agents, such as biologically or chemically active agents, to a target. The invention also relates to pharmaceutical compositions comprising at least one delivery agent compound of the present invention and at least one active agent, and unit dosage forms comprising such compositions. Methods for the preparation and administration of the pharmaceutical compositions are also disclosed.

2,3-Dihydro-7-benzofurancarboxylic Acids

The syntheses of a series of title compounds 1 a-f bearing methyl groups in the heterocyclic part were described.Depending on the substitution pattern the Claisen rearrangement (path A) or the methodology of directed lithiations (path B) were used as the